Protagonist Therapeutics shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Skandinaviska Enskilda Banken AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.2M | 79k | 66.43 |
| 2025-06-30 | $4.6M | 83k | 55.27 |
| 2025-03-31 | $12M | 249k | 48.36 |
| 2024-12-31 | $12M | 311k | 38.51 |
| 2024-09-30 | $10M | 230k | 45.00 |
| 2024-03-31 | $547k | 19k | 28.93 |
| 2023-09-30 | $315k | 19k | 16.65 |
| 2023-06-30 | $522k | 19k | 27.60 |
| 2022-09-30 | $413k | 49k | 8.43 |
| 2022-06-30 | $387k | 49k | 7.90 |
| 2022-03-31 | $1.2M | 49k | 23.68 |
| 2021-12-31 | $1.3M | 38k | 34.25 |
| 2021-09-30 | $679k | 38k | 17.73 |
| 2021-06-30 | $1.4M | 31k | 44.89 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB